Hyderabad Telangana, India

Venkateswar Rao Challagonda

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Venkateswar Rao Challagonda: Innovator in Pharmaceutical Chemistry

Introduction

Venkateswar Rao Challagonda is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of stable amorphous forms of complex compounds. With a total of 2 patents to his name, his work is recognized for its potential impact on drug formulation and delivery.

Latest Patents

Challagonda's latest patents include the "Stable amorphous form of sacubitril valsartan trisodium complex and processes for preparation thereof." This invention relates to the stable amorphous form of the sacubitril valsartan trisodium complex and its solid dispersion compounds. The patent outlines processes for their preparation and pharmaceutical compositions that comprise these compounds. Additionally, it describes an improved process for the preparation of sacubitril sodium and its application in the creation of the sacubitril valsartan trisodium complex.

Career Highlights

Venkateswar Rao Challagonda is currently associated with Laurus Labs Private Limited, a prominent player in the pharmaceutical industry. His work at Laurus Labs focuses on innovative drug formulations that enhance therapeutic efficacy and patient compliance. His expertise in pharmaceutical chemistry has positioned him as a valuable asset to the company.

Collaborations

Challagonda has collaborated with several professionals in his field, including Ravindra Babu Bollu and Ram Thaimattam. These collaborations have fostered a productive environment for innovation and research within the pharmaceutical sector.

Conclusion

Venkateswar Rao Challagonda is a distinguished inventor whose contributions to pharmaceutical chemistry are noteworthy. His patents reflect a commitment to advancing drug formulation technologies, which can significantly benefit the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…